Psychedelic

New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia
Legal Advocate Takes Bold Approach To Address PTSD In Veterans
Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
Legal Advocate Takes Bold Approach To Address PTSD In Veterans
Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
What's Spurring The Growth Of The Psychedelics Market – And How One Company Is Helping As Part Of The Vanguard In This Emerging Field
Sponsored
Elon Musk Takes A Trippy Swipe At Apple's $3,500 Vision Pro Headset: Mushrooms, Aliens, UFOs Involved!

Psychedelic Recent News

This Psychiatrist Says Cannabis Is A Minor-League Psychedelic & Undervalued Investment Opportunity
Cannabis is a psychedelic that belongs to the group of mind-manifesting substances, according to Dr. Julie Holland. "When you get high on cannabis, you can see your thoughts differently, and it can give you a bigger perspective on life," she said in an interview with Rena Sherbill from the Cannabis Investing Podcast.
Ibogaine To Treat Addiction: 5 Reasons Why It's Safer To Do It In Hospital Settings
By Santiago Federico Richetti via El Planteo
Is Psilocybin Therapy A Potential Treatment For Fibromyalgia & Binge Eating Disorder?
Clinical-stage developer of psychedelic compounds Tryp Therapeutics Inc. (OTCQB: TRYPF) filed two provisional patent applications - one for psilocybin therapy for fibromyalgia and another expanding psilocybin-based TRP-8803 development’s IP.  
'Psychedelics Companies Are Onto Something Extraordinary,' Says Kevin O'Leary: Meet Our Keynote Speakers
Whether you're into finances or just a fan of Shark Tank, chances are you know who Kevin O’Leary is. AKA Mr. Wonderful, the Canadian investor of Irish heritage is well known in the finance space and as a TV personality. 
PSYC Launches Spotlight Media Subsidiary As It Prepares For Future Media Expansion
Missouri: Lawmaker Files Bill That Would Decriminalize Psychedelics For Therapeutic Use
Rep. Tony Lovasco (R) from Missouri filed a bill on Tuesday that would legalize the use of psychedelics for therapeutic use at designated care facilities and decriminalize low-level possession, reported Marijuana Moment.
PSYC Corporation Completes Name Change From Global Trac Solutions
PSYC Corporation, formerly known as Global Trac Solutions, Inc. (OTCPK: PSYC) and the company behind psychedelic news and information platform Psychedelic Spotlight, completed the process of changing its corporate name from Global Trac Solutions, Inc. to PSYC Corporation.
MindMed Names Robert Barrow As CEO & Director, Announces Management Shake-Ups
Psychedelic-focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) announced Tuesday that Robert Barrow has been appointed CEO and member of the board of directors.
Virginia Officials Highlight Potential Of Psychedelics In Treating Depression & PTSD
It seems that the therapeutic potential of psychedelics is becoming more generally accepted in Virginia, as activists are hoping to expand upon the state’s current psychedelic decriminalization ordinance.
FDA Shows Support For Development Of MindMed's Session Monitoring System
Psychedelic-focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) recently met with the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) with consultation from the Center for Drug Evaluation and Research (CDER) to
Delic Labs Applies For Dealer's License To Work With MDMA And LSD For Medical Purposes
Psychedelic wellness platform Delic Holding Corp Inc. (CSE: DELC) (OTCQB: DELCF) (FRA:6X0) said Wednesday that Delic Labs has applied for a Health Canada 56 Research Exemption that would allow the scientists to perform research and tests on a host of compounds outside of psychedelic mushrooms, inclu
Virtual Reality And Psychedelic Therapy: Interview With Entheo Digital CEO
This article Jason Najum was originally published on Microdose Psychedelic Insights and appears here with permission.
Delic Teams Up With Paradigm To Create Ketamine Toxicology Testing Solution, Raises $7M For Expansion
Psychedelic wellness platform Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA:6X0) announced Thursday a first of its kind partnership with Paradigm Healthcare, an independent clinical laboratory located in St.
How This Psychedelic Company Could Lead A Turnaround For The Sector
Compass Pathways PLC (NASDAQ: CMPS) is often viewed as the leader in the psychedelic sector with smaller companies such as Mind Medicine (OTC: MMEDF) and Mydecine Innovations Group Inc (OTC:
Psychedelics Stock MindMed Stumbles On 2020 Results
A psychedelic medicine biotech company, Mind Medicine Inc. (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), released full-year 2020 financial
'One-Of-A-Kind' $10 Million Psychedelic Research Center Comes To NYU
This article by Jill Ettinger was originally published on Psychedelic Spotlight, and appears here with permission.
7 Psychedelic Trend Predictions For 2021
This article by Jill Ettinger was originally published on Psychedelic Spotlight, and appears here with permission.
5 Athletes Who Healed With Psychedelic Therapy
This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission.
Inside The Underground World Of Online Psychedelic Support Groups
This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission.
Psychedelic Capital Returns In 2021: January's Event Will Explore The First Raise And Life In Public Markets
This article was originally published on Microdose Psychedelic Insights and appears here with permission. Click here to get your FREE ticket to Psychedelic Capital today!
When The Drop Joins The Ocean: An Evidence-Based And Personal Exploration Of 5-MeO-DMT
This article by Gaurav Dubey was originally published on Microdose Psychedelic Insights and appears here with permission.
'Magical Mushroom' Psilocybin May Help With Clinical Depression
This article was originally published on Cannabis & Tech Today, and appears here with permission. In clinical depression and related disorders, there have not been any significant treatment advancements in over a decade.
3 Reasons Psychedelic Investing May Be A Better Long Term Play Than Cannabis
This article was originally published on Microdose Psychedelic Insight, and appears here with permission.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved